• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS Back to Search Results
Model Number 7278
Medical Device Problem Code Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/27/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The patient/family (a1) was the initial reporter (e1), so personal information was not entered.No information was captured in sections a2 and a4 as the customer's age and weight were not provided.
 
Event or Problem Description
The customer reported that while he was at the physician's office, within 10 minutes he performed a comparison of blood glucose readings between the contour next meter and an alternate meter and received a difference of 40 mg/dl.No specific readings were provided.There was no allegation of an adverse event alleged.The customer was advised to return the device for evaluation.A replacement meter kit was sent to the customer.
 
Additional Manufacturer Narrative
The customer did not return the suspected device for evaluation.Lot # 0epec41b of contour next test strips associated with the event expired in mar-2022.Therefore, the in-house testing could not be performed with the retained samples.The device history record was reviewed for the suspected contour next meter and no manufacturing anomalies were found.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTOUR NEXT
Common Device Name
BLOOD GLUCOSE TEST STRIPS
Manufacturer (Section D)
ASCENSIA DIABETES CARE US INC.
100 summit lake drive
valhalla NY 10595
Manufacturer (Section G)
PHC CORPORATION (REGISTRATION NUMBER: 1000134386)
2131-1 minamigata
toon ehime, 791-0 395
JA   791-0395
Manufacturer Contact
shweta gulati
100 summit lake drive
valhalla, NY 10595
9142361830
MDR Report Key11207004
Report Number1810909-2021-00046
Device Sequence Number3472712
Product Code NBW
UDI-Device Identifier10301937278706
UDI-Public10301937278706
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K121190
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Other
Remedial Action Replace
Type of Report Initial,Followup
Report Date (Section B) 01/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date05/31/2022
Device Model Number7278
Device Catalogue Number7278
Device Lot Number0EPEC41B
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/02/2021
Supplement Date Received by Manufacturer06/08/2022
Initial Report FDA Received Date01/21/2021
Supplement Report FDA Received Date06/09/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/01/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Patient SexMale
-
-